Park Medi World IPO has opened for subscription, bringing a hospital-based healthcare company to the Indian primary market. The public issue comes amid continued demand for organised medical services and increased focus on healthcare infrastructure across the country.
Hospital operators typically follow a capital-intensive business model, making IPOs in this segment closely tracked by market participants. The Park Medi World IPO offers investors exposure to the healthcare services space, which includes inpatient, outpatient, diagnostic, and specialised medical care.
Disclaimer
This article is published strictly for informational and news purposes only. It does not constitute financial advice or an investment recommendation. Readers are advised to refer to official offer documents and consult certified professionals before making investment decisions.
Table of Contents
Key IPO Details (As per NSE Disclosures)
| Particular | Details |
|---|---|
| Company Name | Park Medi World Limited |
| NSE Symbol | PARKHOSPS |
| Security Type | Equity Shares |
| Issue Type | 100% Book Building |
| Issue Status | Active |
| Issue Period | 10 December 2025 – 12 December 2025 |
| Market Timings | 10:00 AM to 5:00 PM |
| Listing Exchanges | NSE and BSE |
Issue Size and Structure
According to the issue information disclosed on the National Stock Exchange (NSE), the Park Medi World IPO comprises:
- Fresh Issue: up to ₹770 crore
- Offer for Sale (OFS): up to ₹150 crore
- Total Issue Size: up to approximately ₹920 crore
The offer also includes an anchor investor portion of 1,70,37,036 equity shares, allocated before the opening of the public issue.
Price Band, Lot Size, and Investment Limits
| Particular | Details |
|---|---|
| Price Band | ₹154 to ₹162 per equity share |
| Face Value | ₹2 per equity share |
| Tick Size | ₹1 |
| Lot Size | 92 equity shares |
| Minimum Application | 92 equity shares |
| Maximum Retail Investment | ₹2,00,000 |
At the upper price band, a retail investor would need to invest close to the prescribed limits for one or more lots, subject to SEBI regulations.
Investor Category-Wise Bid Limits
| Investor Category | Maximum Bid Quantity |
|---|---|
| Qualified Institutional Buyers (QIBs) | 4,18,18,140 equity shares |
| Non-Institutional Investors (NIIs) | 2,98,70,100 equity shares |
| Retail Individual Investors (RIIs) | As per ₹2 lakh cap |
(Quantities calculated at the lower price band, as per NSE disclosures.)
Cut-off Time for UPI Mandate Confirmation
The cut-off time for UPI mandate confirmation for the Park Medi World IPO is:
- 12 December 2025 – up to 5:00 PM
Investors using UPI-based applications must ensure that the mandate is approved before the cutoff. Bids without confirmed mandates may be considered invalid, as per exchange rules.
About Park Medi World Limited
Park Medi World Limited operates in the hospital and healthcare services sector, providing medical care through hospital facilities. The company’s operations include a range of healthcare services covering diagnosis, treatment, surgical procedures, and patient care.
Hospital-based healthcare businesses rely heavily on physical infrastructure, medical equipment, trained professionals, and regulatory compliance. As a result, operating efficiency, capacity utilisation, and service mix play an important role in financial performance.
The company’s revenue is typically generated across multiple departments such as:
- Outpatient consultations
- Inpatient care
- Diagnostics and imaging
- Surgical and specialised treatments
Healthcare Industry Outlook
India’s hospital services sector has expanded steadily due to:
- Growing healthcare awareness
- Rising lifestyle-related diseases
- Increasing insurance penetration
- Demand for organised medical infrastructure
However, hospital operators also face challenges such as high fixed costs, staffing requirements, regulatory obligations, and pricing pressures, particularly in competitive markets.
Use of IPO Proceeds
As per issue disclosures, proceeds from the fresh issue are proposed to be utilised for:
- Strengthening the company’s balance sheet
- Expansion or upgrading of hospital infrastructure
- Investment in medical equipment
- General corporate purposes
Funds raised through the OFS portion will go to selling shareholders and will not be received by the company.
Book Running Lead Managers and Banking Partners
| Role | Details |
|---|---|
| Book Running Lead Managers | Nuvama Wealth Management Ltd, CLSA India Pvt Ltd, DAM Capital Advisors Ltd |
| Sponsor Banks | Axis Bank Ltd, ICICI Bank Ltd |
These entities play a key role in managing the IPO process, underwriting, and regulatory compliance.
How to Apply for the Park Medi World IPO
Investors can apply for the Park Medi World IPO using standard IPO application methods:
ASBA (Application Supported by Blocked Amount)
Applications can be submitted through the net-banking platforms of authorised banks. The application amount remains blocked and is deducted only upon allotment.
UPI-Based Applications
Retail investors can apply through supported broker platforms using UPI. The payment mandate must be approved before the cutoff time to validate the application.
Applicants must have:
- An active demat account
- A linked bank account
- A valid UPI ID (for UPI applications)
Subscription and Post-Issue Timeline
The IPO will remain open from 10 December 2025 to 12 December 2025. During this period, bids can be placed, revised, or withdrawn.
Following the closure of the issue:
- The basis of allotment will be finalised
- Shares will be credited to successful applicants
- Funds will be unblocked for unsuccessful bids
- Equity shares will be listed on the stock exchanges, subject to regulatory approvals
Investors tracking ongoing healthcare listings may also want to read about the Nephrocare Health IPO, which recently opened for subscription amid strong interest in the dialysis services segment.
Conclusion
The Park Medi World IPO adds another hospital-based healthcare company to the public markets. While the healthcare sector offers long-term growth opportunities, hospital operations require careful execution, capital discipline, and efficient utilisation of resources.
Market participants are expected to evaluate the issue based on the company’s operational capabilities, utilisation of IPO proceeds, and long-term sustainability rather than short-term market movements.
